Lv5
1170 积分 2023-09-24 加入
Covalent LYTAC Enabled by DNA Aptamers for Immune Checkpoint Degradation Therapy
4个月前
已完结
A Dual‐Targeting Circular Aptamer Strategy Enables the Recognition of Different Leukemia Cells with Enhanced Binding Ability
5个月前
已完结
A DNA Molecular Logic Circuit for Precise Tumor Identification
5个月前
已完结
Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
6个月前
已完结
Leveraging Aptamer-Based DNA Nanotechnology for Bioanalysis and Cancer Therapeutics
6个月前
已完结
Chemically Engineered Affinity Protein Drugs for Covalent Targeted Cancer Therapy
6个月前
已完结
Synergistic SuFEx‐Driven Covalent Cancer Therapy Using a HER2/EGFR Bivalent Affinity Protein Drug
6个月前
已完结
Evolution of Cross-Linking Aptamers for Long-Lasting Membrane Protein Labeling
6个月前
已完结
Urinary bioorthogonal reporters for the monitoring of the efficacy of chemotherapy for lung cancer and of associated kidney injury
7个月前
已完结
Molecular bioengineering of functional nucleic acids
7个月前
已完结
皖公网安备34019202002308
